Atlas Trials

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Clinical trial NCT01837095 · COMPLETED

Trial details

NCT number
NCT01837095
Sponsor
Polyphor Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-06-01
Primary completion
2018-08-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.